MARKET

KTTAW

KTTAW

PASITHEA THERAPE
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.2700
-0.0353
-11.56%
Closed 16:00 01/14 EST
OPEN
0.3432
PREV CLOSE
0.3053
HIGH
0.3432
LOW
0.2380
VOLUME
73.09K
TURNOVER
--
52 WEEK HIGH
1.590
52 WEEK LOW
0.2380
MARKET CAP
--
P/E (TTM)
-87.0968
1D
5D
1M
3M
1Y
5Y
BRIEF-Pasithea Therapeutics Corp Files For Potential Offering Of 17.7 Mln Shares Of Common Stock Offered By Selling Stockholders
reuters.com · 12/09/2021 22:50
Pasithea Therapeutics Corp. Announces Closing of $30.4 Million Private Placement Priced at a Premium to the Market Under Nasdaq Rules
MIAMI BEACH, Fla., Nov. 29, 2021 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (Nasdaq: KTTA; KTTAW) (“Pasithea” or the “Company”), a biotechnology company focused on the research and discovery of new and effective treatments for psychiatric and neurolog...
GlobeNewswire · 11/29/2021 22:45
Ault Global Holdings Founder Tweets '"Today we sold all 390,000 shares of $KTTA and 390,000 $KTTAW we owned for a very nice win" sold through our subsidiary. $DPW'
https://twitter.com/ToddAultIII/status/1463214310306430981
Benzinga · 11/23/2021 18:35
EXCLUSIVE: Pasithea Therapeutics CEO, Tiago Reis Marques Now Interviewing On Benzinga Live Tv
Click To Tune In Here... https://www.youtube.com/watch?v=FyxiHbVHAQk
Click To Tune In Here...  · 11/23/2021 16:46
BRIEF-Pasithea Therapeutics Adds Esketamine Nasal Spray To Its Clinic Offerings In The U.K.
reuters.com · 11/23/2021 13:32
Pasithea Therapeutics Adds Esketamine Nasal Spray to its Clinic Offerings in the U.K.
Pasithea Clinics is one of only three accredited clinics in the U.K. approved to offer esketamine nasal spray (SPRAVATO®) for treatment of mental health disordersMIAMI BEACH, Fla., Nov. 23, 2021 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (Nasdaq: KTTA...
GlobeNewswire · 11/23/2021 13:00
EXCLUSIVE: Pasithea Therapeutics' Subsidiary Pasithea Clinics Reports It Has Been Approved To Provide Esketamine Nasal Spray (SPRAVATO) For Treatment-Resistant Depression In Adults
Miami Beach, FL / November 23, 2021 -- Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a novel biotechnology company focused on the research and discovery of new and
Benzinga · 11/23/2021 12:30
Pasithea Therapeutics Launches In-Home Intravenous Ketamine Therapy in Major U.S. Cities, Expanding its International Footprint
-- Pasithea Clinics to offer ketamine infusion therapy for the treatment of mental health disorders -- -- First mobile clinics launch in New York City, Los Angeles, San Diego, and San Francisco, with expansion to additional U.S. cities in coming months -- ...
GlobeNewswire · 11/17/2021 13:00
More
Forecast
No Data
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of KTTAW. Analyze the recent business situations of PASITHEA THERAPE through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
  • Performance
  • Asset Allocation
  • Dividend History
No Data
No Data
No Data
About KTTAW
Pasithea Therapeutics Corp. is a biotechnology company. The Company is engaged on psychiatric and neurological research regarding central nervous system (CNS) disorders with focus on translating the research into clinic-ready drugs. The Company's secondary operations are focused on establishing anti-depression clinics across the United Kingdom and providing business support services to similar entities in the United States and using psychiatric assessment combined with physician or medical providers to administer intravenous infusions of ketamine.

Webull offers kinds of Pasithea Therapeutics Corp stock information, including NASDAQ:KTTAW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KTTAW stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading KTTAW stock methods without spending real money on the virtual paper trading platform.